Cemvita

Cemvita develops engineered microbes for converting waste and carbon dioxide into valuable resources through biological conversion. The company applies synthetic biology and circular economy principles to reinvent heavy industrial processes, creating sustainable alternatives for chemical production, fuel generation, and resource recovery. Founded in 2017 and headquartered in Houston, United States, Cemvita has raised $15M in Series A funding from investors including Oxy, United Airlines, Energy Capital Ventures, Mitsubishi, and Sumitomo. The company's bio-engineering platform enables the production of biofuels, biochemicals, and other industrial products from CO2 and waste feedstocks, helping heavy industry decarbonize operations while creating commercially viable products from greenhouse gas emissions.